Oxytocin is a peptide hormone and uterotonic drug that was developed in the early 20th century and has been widely used in obstetrics since its clinical introduction. Its history is marked by its essential role in inducing and augmenting labor, controlling postpartum hemorrhage, and aiding in childbirth management. Oxytocin, which is naturally produced by the hypothalamus and released from the posterior pituitary, was synthesized for medical use to allow controlled administration in labor induction and obstetric care. It is included in standard protocols for active management of the third stage of labor and is also used to stimulate uterine contractions when needed.
BRAND NAMES
Pitocin
Syntocinon
Oxytocin Injection (various generic brands)
MECHANISM OF ACTION
Oxytocin binds to oxytocin receptors on uterine smooth muscle, activating G-protein–coupled pathways that increase intracellular calcium levels. This leads to rhythmic uterine contractions, especially in late pregnancy when receptor density is increased, helping to induce or augment labor and control postpartum bleeding.
PHARMACOKINETICS
Absorption
Oxytocin is not effective orally because it is rapidly degraded in the gastrointestinal tract. It is therefore administered mainly by intravenous infusion or intramuscular injection, where it is quickly absorbed into the bloodstream and produces a rapid uterine response.
Oxytocin has a relatively small volume of distribution, as it mainly remains in the extracellular fluid. It does not extensively bind to tissues and is rapidly distributed in plasma, contributing to its short duration of action.
Oxytocin is rapidly broken down by enzymatic degradation in the liver and kidneys, primarily by oxytocinase (also called placental leucine aminopeptidase). It has a very short half-life due to rapid metabolism in circulation.
Oxytocin is eliminated mainly through enzymatic degradation in the liver, kidneys, and plasma rather than unchanged renal excretion. Its metabolites are cleared rapidly in urine, contributing to its very short duration of action.
PHARMACODYNAMICS
Oxytocin stimulates uterine smooth muscle via oxytocin receptors, increasing intracellular calcium to produce rhythmic uterine contractions. It also causes milk ejection by contracting myoepithelial cells in the breast, with effects enhanced during late pregnancy due to increased receptor sensitivity.
ADMINISTRATION
Oxytocin is administered intravenously as a controlled infusion for labor induction or augmentation, allowing precise titration of uterine contractions, and intramuscularly for prevention or treatment of postpartum hemorrhage. It must be given under close medical supervision with continuous monitoring of uterine activity, fetal heart rate, and maternal vital signs due to the risk of uterine hyperstimulation and fetal distress. In obstetric practice, dosing is carefully individualized and adjusted based on uterine response.
DOSAGE AND STRENGTH
Oxytocin is available in 5 IU/mL and 10 IU/mL injections. It is given as a slow IV infusion for labor induction or 10 IU IM for prevention of postpartum hemorrhage, with careful dose adjustment based on uterine response.
DRUG INTERACTIONS
Oxytocin interacts with other uterotonics, increasing risk of uterine hyperstimulation. Inhalational anesthetics may reduce its uterine effects, while vasoconstrictors can alter blood pressure response.
FOOD INTERACTIONS
Oxytocin has no significant food interactions because it is administered parenterally (IV or IM) and is not affected by digestion or diet. However, it is used in a medical setting where fasting or pre-delivery dietary restrictions may be followed for obstetric safety.
CONTRAINDICATIONS
Oxytocin is contraindicated in situations where vaginal delivery is not advisable, such as cephalopelvic disproportion, fetal distress requiring immediate delivery, or abnormal fetal position. It should not be used in cases of uterine hypertonicity, obstructed labor, or hypersensitivity to the drug.
SIDE EFFECTS
Nausea or vomiting
Headache
Flushing (warm, red skin)
Uterine cramps (expected during labor induction)
OVER DOSE
An overdose of Oxytocin is a serious condition that usually occurs when excessive amounts are administered during labor. It leads to uterine hyperstimulation, causing very strong, prolonged, or frequent contractions that can reduce blood flow and oxygen supply to the fetus, resulting in fetal distress. In severe cases, it may cause uterine rupture.
TOXICITY
Toxicity from Oxytocin occurs when the drug produces harmful effects in the body, usually due to excessive dosing or prolonged administration. The most important toxic effect is uterine hyperstimulation, where contractions become too strong, frequent, or sustained, reducing blood flow to the placenta and leading to fetal distress or even uterine rupture in severe cases.